Methotrexate in rheumatoid arthritis: a quarter century of development
about
Vitamin C enhances anticancer activity in methotrexate‑treated Hep3B hepatocellular carcinoma cellsThe possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge.The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritisComparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study).Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH).Rational Design of Benzylidenehydrazinyl-Substituted Thiazole Derivatives as Potent Inhibitors of Human Dihydroorotate Dehydrogenase with in Vivo Anti-arthritic Activity.Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?To stop the erosion of hope: the DMARD category and the place of semantics in modern rheumatology.Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.Methotrexate, blood pressure and markers of arterial function in patients with rheumatoid arthritis: a repeated cross-sectional study.Radiolabeled methotrexate as a diagnostic agent of inflammatory target sites: A proof-of-concept study.The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients
P2860
Q34000663-C51C3520-0C71-414A-BDD0-F9A6BADA3AB7Q34945967-DFEDE86D-E181-4C0F-AC0D-BEE122A44549Q35741946-A15BE37B-377A-4D6F-BC90-142AB2B76801Q35789299-5DECEE20-2AD2-4C6D-8D06-F70B09E2B0DBQ35990760-94C0898B-6DDF-4C67-8EF4-7299A8A5A009Q36129211-224D8123-EA86-4E00-A5F1-FBD2ACC7A1CFQ36575283-CC0CBCEC-DB6B-460B-A5EE-FB525A7276D2Q38380873-0BBEC234-0A24-4F94-83B8-12B55663212CQ39004042-102406FC-831F-4475-BBD8-64263600C5B4Q41718646-AED4BF44-B899-491B-9493-300CEF3023BEQ47328755-7EF35F6E-3A58-4928-83A3-F806B1AAF767Q57816122-13114783-2D75-456F-AEF5-AC46D3ECAB23
P2860
Methotrexate in rheumatoid arthritis: a quarter century of development
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Methotrexate in rheumatoid arthritis: a quarter century of development
@ast
Methotrexate in rheumatoid arthritis: a quarter century of development
@en
Methotrexate in rheumatoid arthritis: a quarter century of development
@nl
type
label
Methotrexate in rheumatoid arthritis: a quarter century of development
@ast
Methotrexate in rheumatoid arthritis: a quarter century of development
@en
Methotrexate in rheumatoid arthritis: a quarter century of development
@nl
prefLabel
Methotrexate in rheumatoid arthritis: a quarter century of development
@ast
Methotrexate in rheumatoid arthritis: a quarter century of development
@en
Methotrexate in rheumatoid arthritis: a quarter century of development
@nl
P2860
P3181
P1476
Methotrexate in rheumatoid arthritis: a quarter century of development
@en
P2093
Michael E Weinblatt
P2860
P3181
P407
P577
2013-01-01T00:00:00Z